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SUMMARY
Despite the overlapping distribution of Schistosoma haematobium and Plasmodium falciparum infections, few studies have
investigated early immune responses to both parasites in young children resident in areas co-endemic for the parasites. This
study measures infection levels of both parasites and relates them to exposure and immune responses in young children.
Levels of IgM, IgE, IgG4 directed against schistosome cercariae, egg and adult worm and IgM, IgG directed against
P. falciparum schizonts and themerozoite surface proteins 1 and 2 together with the cytokines IFN-γ, IL-4, IL-5, IL-10 and
TNF-αwere measured by ELISA in 95 Zimbabwean children aged 1–5 years. Schistosome infection prevalence was 14·7%
and that ofPlasmodium infection was 0% in the children. 43. 4% of the children showed immunological evidence of exposure
to schistosome parasites and 13% showed immunological evidence of exposure to Plasmodium parasites. Schistosome–
speciﬁc responses, indicative of exposure to parasite antigens, were positively associated with cercariae-speciﬁc IgE re-
sponses, while Plasmodium-speciﬁc responses, indicative of exposure to parasite antigens, were negatively associated with
responses associated with protective immunity against Plasmodium. There was no signiﬁcant association between
schistosome-speciﬁc and Plasmodium-speciﬁc responses. Systemic cytokine levels rose with age as well as with schistosome
infection and exposure. Overall the results show that (1) signiﬁcantly more children are exposed to schistosome and
Plasmodium infection than those currently infected and; (2) the development of protective acquired immunity commences in
early childhood, although its eﬀects on infection levels and pathology may take many years to become apparent.
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INTRODUCTION
There is considerable overlap in the geographical
distribution of the two human parasites, Schistosoma
haematobium and Plasmodium falciparum, and the
prevalences of both parasites in exposed individuals
rise with age, peaking in childhood. Schistosome
infection in children below 5 years of age had, until
recently, largely been ignored as a result of two pre-
vious misconceptions; (1) that such young children
are not suﬃciently exposed to water containing viable
schistosome cercariae to acquire signiﬁcant levels of
infection, and (2) that low levels of infection carried
by pre-school children did not translate into severe
morbidity (Stothard and Gabrielli, 2007). With the
growing evidence that children aged 5 years and
below do carry signiﬁcant levels of schistosome infec-
tion (Maﬁana et al. 2003; Sousa-Figueiredo et al.
2008; Uneke and Egede, 2009;Garba et al. 2010), and
morbidity (Garba et al. 2010) and the indication that
this same age group can suﬀer from severe malaria
(Oduro et al. 2007), there is a need to understand the
interaction between the two parasites in these young
children in terms of disease aetiology and impact on
child health and development. The pathophysiology
of both parasitic infections is immune-mediated,
such as cerebral malaria or schistosome granuloma
and ﬁbrosis (Mott and Chen, 1989; Maitland and
Marsh, 2004). However co-infection is known to
modulate immune responses, potentially altering the
pathophysiological and immunological proﬁles of
disease (Booth et al. 2004b,c). To date there is a
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paucity of studies describing the burden of
Schistosoma haematobium infection in children aged
5 years and below and even fewer studies characteriz-
ing the early schistosome speciﬁc immune responses
in these children. There are relatively more studies
of Plasmodium-speciﬁc immune responses in young
children but fewer studies characterizing schistosome
and Plasmodium-speciﬁc responses in children con-
currently exposed to both parasites.
Investigating the earliest immune responses result-
ing from exposure to schistosome and Plasmodium
antigens in childhood not only informs on the nat-
ure and development of pathological/protective re-
sponses, but also on the phenotype of systemic
immune responses at this young age. Therefore we
have investigated the relationship between exposure
to both parasites and the development of parasite-
speciﬁc antibody responses. The study focused on
immune responses indicative of recent exposure to
infection as well as immune responses associated with
resistance to infection/re-infection. Parasite-speciﬁc
IgM responses are associated with recent exposure to
parasites and several studies have shown this to be
true for both Plasmodium and schistosome parasites
(Mutapi et al. 1997; Ndhlovu and Woolhouse, 1996;
Naus et al. 2003a). In Plasmodium infections, IgG1
and IgG3 antibody sub-classes are associated with
protection against the merozoite surface proteins
(MSP) antigens (Bouharoun-Tayoun and Druihle,
1992; Cavanagh et al. 2004). Studies on S. haemato-
bium indicate that the balance between adult schisto-
some-speciﬁc IgE and IgG4 is one of the key
indicators of the development of protective immunity
to infection (Hagan et al. 1991) while anti-cercariae
IgE and IgG4 responses are associated with the
hypersensitivity reaction causing cercarial dermatitis
(Kourilova et al. 2004; Lichtenbergova et al. 2008).
Anti-egg IgG4 responses have been associated with
pathology in S. mansoni infected Brazilians (Silveira
et al. 2002) and anti-egg IgE has been associated
with immunity to re-infection with S. japonicum
(Zhang et al. 1997). Therefore, this study focused on
total IgM IgG responses against crude Plasmodium
schizont antigen (to determine exposure to
P. falciparum parasites), IgM against schistosome
antigens (to determine exposure to S. haematobium
infections), IgG responses against two P. falciparum
vaccine candidates, merozoite surface protein (MSP)-
1 and MSP-2 we have previously reported on from
Zimbabwean populations (Reilly et al. 2008) and
anti-schistosome IgE and IgG4 as indicators of
the development of putatively protective acquired
immunity and as risk factors for immunopathology.
Cytokines contribute both to infection-related
pathological processes and the development of pro-
tective immunity to these parasites (Booth et al.
2004a; Hunt and Grau, 2003). Interleukin (IL)-10
and interferon-gamma (IFN-γ) are involved in iso-
type switching to protective IgG sub-classes in
Plasmodium infections (Garraud et al. 2003), while
IL-4, IL-5 and IL-10 appear to be important for the
development of resistance to schistosome infection
(Pearce and MacDonald, 2002). There is a growing
body of evidence suggesting that there is a signiﬁcant
interaction in the development of protective immu-
nity and pathology in individuals co-infected with
these parasites (Arinola, 2005; Diallo et al. 2010;
Remoue et al. 2003; Wilson et al. 2008), but there are
few studies in young children. A study in Senegal
compared systemic cytokine levels in children aged
7–15 years to those in adults aged over 30 years and
showed that children co-infected by S. haematobium
had higher levels of IFN-γ and sTNF-RII compared
to children infected only by P. falciparum. In con-
trast, co-infected adults showed a signiﬁcant increase
in IFN-γ, IL-10, TGF-β, sTNF-RI and sTNF-RII,
RANTES and the IL-10/TNF-α ratio (Diallo et al.
2004). The role of childhood infections in determin-
ing future responsesmounted to self andnon-self anti-
gens is an area of active interest (van den Biggelaar
and Holt, 2010).
For this study, systemic cytokines indicative of
CD4+T cell-mediatedT helper (Th)1 andTh2-type
responses were selected for investigation, as these are
amongst the main immunological correlates of patho-
logy and protective immunity to Plasmodium and
schistosome infections (Pearce and MacDonald,
2002; Maizels and Yazdanbakhsh, 2003; Hunt and
Grau, 2003; Booth et al. 2004a; Lyke et al. 2004;
Awandare et al. 2006). IFN-γ, and TNF-α are
markers of Th1 responses, IL-4 and IL-5 aremarkers
for Th2 responses, and IL-10, originally classiﬁed as
both a Th1 and Th2 cytokine in humans (Del Prete
et al. 1993), is now also seen as a marker for immuno-
modulation and regulatory responses (van den
Biggelaar et al. 2000; Hesse et al. 2004; McKee
and Pearce, 2004). Regulatory responses appear
to play an important role in limiting immunopatho-
logy in single-species infections (Malaquias et al.
1997; Hunt and Grau, 2003; Booth et al. 2004a) and
may also be important in malaria-schistosome co-
infection.
The aim of this study was to determine the level of
infection with, and exposure to S. haematobium and
P. falciparum in children aged 1–5 years resident in
villages endemic for both parasites and relate this to
the development of parasite-speciﬁc immune res-
ponses and levels of systemic cytokines.
MATERIALS AND METHODS
Study area
The study was conducted in two villages, Magaya
and Chitate, in the Mashonaland East Province of
Zimbabwe (31°90′E; 17°63′S) where S. haematobium
is endemic. The participants are involved in ongoing
studies on the control and immuno-epidemiology of
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human schistosomiasis. The main activity in these
villages is subsistence farming and human water
contact is frequent with at least 4 contacts/person/
week (assessed by questionnaire) due to insuﬃcient
safe water and sanitation facilities. The rivers in the
two villages diﬀer in their temporal patterns; those in
Magaya are mostly perennial while those in Chitate
are seasonal, leading to diﬀerent schistosome trans-
mission dynamics. Older children are exposed to
infective water actively while younger children are
also exposed passively (e.g. sitting in a container with
infective water) (Stothard and Gabrielli, 2007) as
indicted by questionnaire responses of their parents/
guardians. Plasmodium falciparum is the predomi-
nant species of malaria in Zimbabwe (Taylor and
Mutambu, 1986) where malaria transmission is
largely unstable in nature. Approximately 5·5 million
people out of a total population of 12·7 million live in
malarious areas (StanleyMidzi et al. 2004). Out of the
56 districts in Zimbabwe, malaria transmission
occurs in 42. In 2002, a revised stratiﬁcation based
on a national parasite prevalence survey, Health
Management Information Systems (HMIS) data,
entomological data and expert opinion classiﬁed our
study area under the sporadic transmission regions
with low transmission (Mabaso et al. 2005, 2006)
meaning that this is a mesoendemic area for
Plasmodium transmission and malaria (Mharakurwa
et al. 2004). The peak P. falciparum transmission
occurs from February to May (Mharakurwa et al.
2004) and the annual incidence of malaria in the area
is 1–10 cases/1000 people (Mabaso et al. 2006; Hay
et al. 2009). The study was conducted in February.
Ethical statement
Permission to conduct the study in the region was
obtained from the Provincial Medical Director.
Institutional and ethical approval was received from
the University of Zimbabwe and the Medical
Research Council of Zimbabwe respectively. At the
beginning of the study, parents and guardians of
participating children had the aims and procedures of
the project explained fully in the local language,
Shona, and written consent was obtained from
participants’ parents/guardian before enrolment
into the study. After collection of all samples, all
participants and their parents/guardians were oﬀered
anthelmintic treatment with the recommended dose
of praziquantel (40 mg/kg of body weight).
Sample collection and inclusion criteria
Stool and urine specimens were collected from each
participant on 3 consecutive days and examined
microscopically for S. haematobium, S. mansoni
and geo-helminths following standard procedures
(Katz et al. 1972; Mott, 1983). The formol-ether
concentration method was performed as previously
described (Cheesbrough, 1998; Midzi et al. 2008) on
a random sample of the stool samples to conﬁrm
results obtained by the Kato-Katz technique. For
infants, samples were collected overnight if it was not
possible to collect a sample on the spot. A maximum
of 5ml of venous blood was collected and processed
as previously described (Mutapi et al. 2008) for
Plasmodium detection cytokine and antibody assays.
Thick and thin smear slides were prepared per
participant upon blood collection for the microscopic
detection ofPlasmodium parasites. Results from these
examinations were conﬁrmed using the rapid
Paracheck dipstick (Orchid Biomedical Systems).
Plasma samples were stored at −20 °C and freighted
frozen to Edinburgh where they were thawed for the
assays described below.
In order to be included in the study, participants
had to meet all the following criteria: (1) have been
resident in the study area since birth; (2) provided at
least two urine and two stool samples on consecutive
days; (3) be negative for intestinal helminths includ-
ing S. mansoni (no-one was excluded on this criteria
as everyone was negative for these infections as is
reported in other parts of Zimbabwe (Midzi et al.
2010) and (4) have given a blood sample for the
collection of sera. A total of 95 (54 from Magaya and
41 from Chitate) participants aged 1–5 years met
these criteria and formed our study population.
Parasite antigens
Lyophilized soluble S. haematobium adult worm
antigen (WWH), cercariae antigen (CAP) and soluble
egg antigen (SEA) were obtained from the Theodor
Bilharz Institute (Egypt) and reconstituted as de-
scribed elsewhere (Mutapi et al. 2005). The parasite
strain is one used for our previous immuno-
epidemiology studies (Milner et al. 2010; Mutapi
et al. 2008; Reilly et al. 2008). The P. falciparum
antigens were those previously used in a study in
Zimbabwe (Reilly et al. 2008) and included crude
schizont antigen and the recombinant merozoite sur-
face protein (MSP) antigens prepared in Escherichia
coli, MSP-119 antigen also known as p190, gp195,
(Burghaus and Holder, 1994; Holder et al. 1994) and
two full-length recombinant MSP-2 antigens,
namely CH150/9 (5/6) and Dd2 (13/14) (Metzger
et al. 2003). MSP-2 has 2 serotypes: CH150/9 5/6 is
taken from serotype A (3D7-like), and Dd2 belongs
to serotype B (FC27-like).
Antibody assays
IgM, IgE and IgG4 speciﬁc for schistosome antigens
from the three life stages (cercariae, egg and adult)
were measured by indirect enzyme linked immuno-
sorbent assays (ELISA) as previously described
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(Mutapi et al. 1997). P. falciparum-speciﬁc responses
(IgM and IgG) were also measured by ELISA as
previously described (Aribot et al. 1996; Oeuvray
et al. 1994; Theisen et al. 1998). Brieﬂy, ELISAs
were conducted in duplicate for each sample using
ELISA plates (Nunc-Immulon, Denmark) that were
coated with 50 μl/well of 50 ng/ml antigen for recom-
binant antigens and 1 μg/ml for both crude antigens
in 60mM carbonate-bicarbonate buﬀer (pH 9·6) and
incubated overnight at 4 °C. Plates were blocked with
200 μl/well of skimmed milk (5% milk in phosphate
buﬀered saline (PBS)/0·03% Tween 20) for 1 hr and
washed three times in PBS/Tween 20, which was
used for all washes. 100 μl of serumwas added to each
well at 1:100 dilution for all assays; plates were
incubated at 37 °C for 2 hours and then washed three
times. 100 μl of subclass-speciﬁc monoclonal anti-
body (IgM for crude antigens and IgG for both crude
and recombinant antigens, both from Dako UK)
were added at 1:1000 dilution for crude antigens and
1:2000 dilution for recombinant antigens. Plates were
incubated overnight at 4 °C, washed six times and
50 μl of ABTS substrate solution (KPL, Canada) was
added, before the absorbance was read at 405 nm.
Negative controls from 5 age-matched schistosome
and Plasmodium naïve European donors (aged
1–5 years old) were included in duplicate on each of
the IgM plates to indicate cut-oﬀ points for reac-
tivity, while 2 negative controls were included on the
rest of the plates.
The anti-schistosome egg IgM antibodies were
also used diagnostically based on exposure to egg
antigens as recently reported in a study in preschool
children exposed to S. mansoni infection in Uganda
(Stothard et al. 2011). Anti-cercariae IgM and anti-
schizont IgMwere used to indicate recent exposure to
schistosome cercariae and Plasmodium schizonts as
previously described for schistosomiasis (Woolhouse
et al. 2000) and Plasmodium respectively (Naus et al.
2003b). To determine if children showed recent ex-
posure to parasites (schistosome cercariae, worm or
egg, or Plasmodium schizonts), levels of the parasite-
speciﬁc antibodies (optical densities) had to be
greater than the mean+2 standard deviations of the
negative controls.
Cytokine assays
Circulating levels of IFN-γ, IL-4, IL-5, IL-10 and
TNF-α in plasma samples were conducted using
capture ELISA with antibody capture/detection
pairs and standards from BD Biosciences following
previously published protocols (Joseph et al. 2004;
Milner et al. 2010) andmanufacturer’s guidelines. All
assays were conducted in duplicate. People with
cytokine levels above zero ng/ml (after the subtrac-
tion of the blank control) were denoted positive for
the cytokine while those with concentrations of zero
ng/ml or below were designated as having no
detectable levels of the cytokine.
Statistical analyses
Infection prevalence was compared between villages
by Chi-squared test. For analyses on antibody levels
the continuous optical density data were used to
ensure that the early dynamics of the parasite-speciﬁc
immune responses could be captured even in children
producing low levels of the antibodies. Thus levels of
antibodies directed against the diﬀerent schistosome
crude antigens were compared using the non para-
metric Kruskal Wallis test (data did not satisfy the
assumptions of parametric tests) while antibody
responses against P. falciparum crude antigens were
compared using theMann-Whitney Test. The eﬀects
of host sex (categorical, male and female), age (3
categories, 1–3 years, 3.1 yrs–4 years and 4.1–5 years
to give suﬃciently large sample sizes for statistical
analyses), village (categorical, Magaya and Chitate)
and schistosome infection level either as a categorical
variable (egg positive or egg negative) or continuous
variable (log (x+1) transformed) on antibody level
(square root transformed) were tested using an analy-
sis of variance. Sequential sums of squares were used
to account for variation due to all other factors before
testing for the eﬀects of schistosome infection level
and the interaction between village and age group (to
determine the presence of a peak shift) (Mutapi et al.
1997).
Given that the study measured several immune
variables, i.e. 9 schistosome-speciﬁc responses, 5
Plasmodium-speciﬁc responses and 5 cytokines,
reducing the number of variables was used as a
means of identifying dynamics of exposure and the
development of parasite-speciﬁc acquired immunity.
Thus all the parasite-speciﬁc antibody variables and
cytokine variables were reduced into uncorrelated
variables by factor analysis, a standard technique for
reducing multivariate data to its main independent
features, by transforming several correlated variables
into fewer uncorrelated variables called principal
components (Sokal and Rohlf, 1995). The com-
ponents are extracted according to the amount of vari-
ation in the data they explain, so the ﬁrst component
explains themost variation and each subsequent com-
ponent is included if it explains a signiﬁcant amount
of the remaining variation within the data (Sokal and
Rohlf, 1995). Principal components with eigenvalues
greater than one were extracted by regression analysis
and an extracted component was considered reliable
if it had one or more of the original variables with
factor loadings 56 or 4 – 6 and below. Principal
component regression factor scores for each partici-
pant were used in analyses of variance to determine
their relationship with host factors (sex, age group,
village, schistosome infection intensity and the
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village×age group interaction). After exploratory
plots, one tailed Pearson correction analyses was
conducted to determine the relationship between PCs
while controlling for host sex, age group, village, and
schistosome infection intensity.
RESULTS
Parasite infection levels
The children came from 2 villages endemic for
S. haematobium infection; an initial survey of
1980 permanent residents of the study villages
aged 1–80 years showed that schistosome infection
prevalence was signiﬁcantly higher in Magaya
(prevalence=69%, 95% CI: 63% to 75%) than in
Chitate (prevalence=14%, 95% CI: 11% to 18%)
(χ2=187, df=1, P<0·001), as was infection intensity
58 eggs/10 ml urine (Standard error of the mean
(SEM)=8·02) and 15 eggs/10 ml urine (SEM=4·17)
respectively (F1,612=201, P<0·001). The World
Health Organisation’s classiﬁcation guidelines classi-
fyMagaya as a high infection area (i.e. more than 50%
of the population infected) and Chitate as a low
infection area (i.e. less than 10% of the population
infected) (WHO, 2002). Amongst the 1–5 year olds
participating in this study, the overall prevalence of
S. haematobium infection was 14·7%, (95% CI=13–
36·4%) with 13 out of 54 children in Magaya being
infected and only 1 child from Chitate being infected
(prevalence=2·6%, 95% CI=0·06%–13·5%). Infec-
tion prevalence was signiﬁcantly diﬀerent in the
two villages (X2=7·8, P<0·001). Similarly infection
intensity was signiﬁcantly diﬀerent in the two villages
(F1,94=5·88, P=0·020) with mean infection inten-
sity in Magaya being 17·5 eggs per 10ml urine
(SEM=9·5) and infection rage 0–458 eggs/10 ml
urine and the only infected child in Chitate excreting
1 egg/10ml urine. While the presence of schistosome
infection was apparent from the youngest age group
in Magaya, the high infection area (age of youngest
egg positive child: 3 years 0 months), the only child
excreting schistosome eggs in Chitate, the low
infection area, was aged 4 years and 6 months.
Schistosome infection levels in Magaya and Chitate
partitioned by age are shown in Table 1. These infec-
tion patterns were consistent when anti-egg IgM
responses were used for diagnosing schistosome
infection, which gave a prevalence of 24·4% in
Magaya (95% CI=12·9–39·5%) (the youngest in-
fected person here was 3 years of age) and 7·7% in
Chitate (95% CI=1·6–20·9%) (the youngest infected
person here was 4 years of age). The age proﬁles of
schistosome infection measured by egg counts was
comparable to that measured by the presence of egg-
speciﬁc immune responses in both villages as shown
in Fig. 1. There were no P. falciparum parasites
detected in the blood of any of the children by thick
or thin smears and these results were conﬁrmed by
the rapid Paracheck serological test.
Parasite-speciﬁc antibody responses
Schistosome–speciﬁc responses directed against
cercariae and eggs were signiﬁcantly higher than
those directed against adult worms (Table 2). When
compared to Zimbabweans, schistosome- and
Plasmodium-naïve European controls had lower
means and ranges of schistosome-speciﬁc antibodies
as shown in Fig. 1A. When using these controls as
cut-oﬀs (i.e. mean±2 standard deviations), 43·4% of
the children had levels of anti-cercariae IgM above
those of European donors, indicating that these
children had been exposed to cercariae antigens.
27·4% of the children (all of whom had anti-cercariae
IgM levels above those of the controls) had anti-adult
worm responses, above those of the controls. Thus
signiﬁcantly more children had been exposed to
schistosome antigens than the proportion who were
excreting schistosome eggs (X2=9·07, P=0·005).
Furthermore, the proportion of children with anti-
schistosome IgM levels (against all life stages) above
that of the controls was signiﬁcantly higher in
Magaya (60%) compared to Chitate (23·7%,
X2=10·7, P=0·001). In both villages, the proportion
Table 1. Schistosome infection level in the study population
Magaya (High infection area) Chitate (low infection area)
Infection
intensity
range
(sample size)
Infection
intensity
mean*
(SEM)**
Infection
prevalence
Infection
intensity
range
(sample size)
Infection
intensity
mean
(SEM)
Infection
prevalence
1–3 years old 0–22 (7) 3·14 (3·14) 14·3% 0 (11) 0 0
3.1–4 years old 0–458 (18) 25·44 (25·44) 6·6% 0 (19) 0 0
4.1–5 years old 0–268 (31) 16·26 (9·09) 35·5% 0–1 (9) 0·04 (0·04) 11·1
Total 0–458 (56) 17·57 (9·50) 23·2% 0–1 (39) 0·01 (0·01) 2·6
* =arithmetic mean.
** SEM=Standard error of the mean.
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of children showing evidence of exposure to schisto-
somes rose with age although this was not statistically
signiﬁcant (Fig. 1B). Titres of Plasmodium crude
schizont-speciﬁc IgM were signiﬁcantly higher than
those for IgG (Z=−5, 53, P <0·001), whilst among
the recombinant antigens; titres were highest against
MSP-2(Dd2) antigen. 13% of the children had anti-
schizont IgM levels above those of the negative con-
trols whose raw data (antibody titres) are shown in
Fig. 1A.
Further analyses to determine the factors associ-
ated with antibody levels showed that there were no
signiﬁcant diﬀerences in antibody levels in male
compared to female children. Levels of IgM directed
against all schistosome parasite stages rose with host
age (Fig. 2A) regardless of their village of residence;
however this relationship was signiﬁcant only for
anti-worm IgM (Table 2). Age also had a signiﬁcant
eﬀect on anti-cercariae IgG4. Anti-MSP-2(Dd2)
rose with age (Fig. 2B) although this relationship
was not signiﬁcant (Table 2) while both IgM directed
against Plasmodium total schizont and total IgG
directed against MSP-2(CH150) declined with host
age (Fig. 2B, Table 2). There were diﬀerences in the
levels of parasite-speciﬁc responses mounted by chil-
dren resident in the diﬀerent villages. The majority
of schistosome-speciﬁc responses were higher in
Magaya (high infection area) compared to Chitate
Fig. 1. Parasite-speciﬁc IgM responses. (A) Comparison of individuals’ parasite-speciﬁc IgM antibody levels
in the Zimbabwean study group (closed circles) compared to European donors (open squares) for each parasite antigen
for Schistosoma haematobium (Sh) (CAP=cercariae antigen preparation, SEA=soluble egg antigen, WWH=soluble
adult worm antigen) and Plasmodium falciparum (Pf) (Scz=schizont). Mean and standard error of the mean is shown for
each population. (B) Comparison of schistosome infection prevalence determined by egg count and by egg-speciﬁc
antibodies vs. presence and exposure to parasite antigens. The ﬁgure shows the percentage of people with at least 1 egg
in 10ml urine (Egg +ve), the percentage of people with anti-egg IgM levels (SEA IgM +ve) above the control cut-oﬀ
and, the percentage of people with anti-cercariae (CAP IgM +ve) above the control cut-oﬀ taken to indicate exposure to
cercariae.
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(low infection area) (Table 2). Only anti-worm IgG4
responses were higher in Chitate compared to
Magaya. The converse was true for anti-Plasmodium
responses, with the diﬀerence being signiﬁcant
only for responses against the schizont and MSP-2
(CH150). Having allowed for the eﬀects of sex, age
and village of residence, the relationship between
infection intensity and antibody levels was tested.
This showed that levels of all anti-schistosome anti-
bodies were higher in egg positive children compared
to egg negative children and the converse was true for
Plasmodium-speciﬁc responses (Table 2). The rela-
tionship was signiﬁcant only for anti-schistosome egg
IgG4 and anti-PlasmodiumMSP-2(Dd2). The inter-
action between village and age group had a signiﬁcant
eﬀect on anti-schistosome egg IgE and IgG4, show-
ing that the development of these responses with host
age diﬀer between the two villages.
Relationship between exposure and acquired immunity
Factor analysis reduced, all of the 9 schistosome-
speciﬁc immune responses to 3 components shown
in Table 3. The ﬁrst component Sh-PC1 accounting
for the highest variance was composed of all the anti-
schistosome IgM responses and anti-egg IgE and
IgG4. This component reﬂected exposure to schisto-
some antigens and was signiﬁcantly associated with
schistosome infection intensity, being higher in egg
positive children after allowing for host sex, age
and village (Table 4A). The second component Sh-
PC2was composed of IgE directed against cercariae,
previously shown to be associated with hypersensi-
tivity in the skin. The only factor aﬀecting levels of
this component was village, with people in the low
infection area having signiﬁcantly higher levels than
people residing in the high infection area. However,
this component was signiﬁcantly correlated with
levels of Sh-PC1after controlling for age, sex, village,
or schistosome infection (Table 4B). The last com-
ponent Sh-PC3 was made up of anti-worm IgE
and IgG4. Anti-worm IgE was negatively loaded
in component 3, implying an inverse relationship
with anti-worm IgG4 (Table 4A). Thus low scores
for this component are analogous to an increase in
the adult worm-speciﬁc IgE:IgG4 ratio, which is
associated with development of resistance to schisto-
some infection. Sh-PC3 was not signiﬁcantly associ-
ated with host sex, age, village of residence or
schistosome infection (Table 4A) but was positively
correlated with the ﬁrst component Sh-PC1
(Table 4B).
The ﬁve anti-Plasmodium antibody responses
reduced to 2 principal components (Table 5), the
ﬁrst component, (Pf-PC1) explaining 42% of the
variation was made up of the anti-schizont responses
and antiMSP-2(Dd2) responses. These responses are
indicative of exposure to Plasmodium schizont anti-
gens and these responses declined signiﬁcantly with
Table 2. Analysis of variance F and (P) values of the factors aﬀecting parasite-speciﬁc antibody levels and
systemic cytokines
Antibody/
Cytokine Antigen Sex Age-group Village
Infection
status
Village*Age
group
interaction
S. haematobium IgM CAP 0·35(0·70) 0·87(0·42) 0·37(0·54) 1·27(0·26) 1·42(0·25)
SEA 0·11(0·89) 0·43(0·65) 0·28(0·60) 2·36(0·13) 0·06(0·94)
WWH 1·17(0·32) 5·17(0·009) 15·37(<0·001) 1·46(0·23) 0·19(0·83)
IgE CAP 0·72(0·49) 1·77(0·18) 13·25(0·001) 0·97(0·33) 0·56(0·57)
SEA 0·12(0·89) 1·37(0·26) 1·70(0·20) 0·39(0·54) 3·27(0·05)
WWH 0·15(0·87) 0·004(0·996) 2·30(0·14) 0·67(0·42) 1·11(0·34)
IgG4 CAP 1·46(0·21) 3·18(0·05) 0·96(0·33) 1·74(0·19) 0·42(0·66)
SEA 1·99(0·15) 1·08(0·35) 2·41(0·13) 8·52(0·005) 3·08(0·05)
WWH 0·01(0·99) 0·96(0·39) 6·59(0·013) 3·40(0·07) 1·05(0·36)
P. falciparum IgM TSz 0·95(0·31) 4·28(0·018) 66·56(<0·001) 2·86(0·10) 0·42(0·66)
IgG TSz 0·80(0·45) 1·56(0·21) 29·87(<0·001) 1·85(0·18) 0·55(0·58)
MSP-119 0·90(0·41) 0·83(0·43) 0·19(0·67) 0·11(0·74) 0·77(0·47)
MSP-2
(CH150)
0·90(0·41) 14·21(<0·001) 76·64(<0·001) 0·34(0·56) 0·83(0·44)
MSP-2(dD2) 0·45(0·62) 0·03(1) 1·67(0·20) 4·49(0·038) 0·79(0·46)
Cytokines IFN-γ 0·22(0·64) 0·87(0·42) 0·04(0·84) 1·71(0·20) 0·06(0·95)
TNF-α 1·38(0·25) 1·25(0·29) 0·17(0·68) 0·23(0·63) 0·35(0·71)
IL-4 3·97(0·06) 2·29(0·11) 23·3(<0·001) 0·86(0·36) 5·04(0·01)
IL-5 0·1(0·96) 0·15(0·86) 0·02(0·89) 1·51(0·22) 0·11(0·90)
IL-10 5·23(0·026) 2·2(0·12) 0·23(0·63) 0·91(0·34) 0·78(0·46)
Schistosome-speciﬁc antibody levels were measured against cercariae (CAP), adult worm (WWH) and egg (SEA) antigens.
Plasmodium antigens were measured against total schizont (Tsz) and the recombinant proteins Merozoite Surface protein
(MSP)-119, MSP-2(CH150) and MSP-2(dD2). P values signiﬁcant at P<0·05 are highlighted in bold.
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age (Table 4A). Furthermore, these responses were
signiﬁcantly higher in Chitate, the low schistosome
infection area but had no relationship to schistosome
infection or host sex. Anti-MSP-119 and MSP-2
(CH150) responses were grouped in component 2
(Pf-PC2), which explained 24% of the variation.
These responses are indicative of the development of
immunity against Plasmodium infection and were not
related to host age, sex, village, or schistosome infec-
tion. However, they were negatively correlated to
the Pf-PC1 responses after controlling for the eﬀects
of age, sex, village and schistosome infection
(Table 4B).
Cytokine responses
To allow direct comparisons between cytokines, the
number of people with detectable systemic cytokine
levels was determined and compared rather than the
absolute values (absolute levels of cytokines varied on
diﬀerent scales with IL-4 and IFN-γ levels being in
ng/ml while levels of IL-10 were in pg/ml). Most
participants had detectable levels of IL-10, followed
by IL-4 with the least number of participants having
detectable TNF-α (Fig. 3A). Only 2 children (both
5 years of age, one positive for schistosome eggs
and the other negative) had detectable levels of all
n
m
Fig. 2. Parasite speciﬁc age-antibody proﬁles. Open bars=1–3 years old, grey bars=3 > to 4 years,
black bars=4 > to 5 years. Standard error of the mean is shown for each bar. (A) Schistosoma haematobium -speciﬁc
responses (CAP=cercariae antigen preparation, SEA=soluble egg antigen, WWH=soluble adult worm antigen
preparation. (B) Plasmodium falciparum-speciﬁc responses (MSP=Merozoite Surface Protein).
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5 cytokines. The proportion of children producing
each cytokine did not vary signiﬁcantly with host age,
sex, and village or schistosome infection. When the
eﬀects of host sex, age, village and schistosome infec-
tion on the concentrations of each cytokine was
assessed, sex was found to signiﬁcantly aﬀect levels of
IL-10, with females having higher levels than males.
The relationship between IL-4 and age was also
found to diﬀer between the two villages (Table 2).
Factor analysis reduced all the cytokines into a
single variable (Table 6) composed of IL-5, IL-10
and IFN-γ. Levels of this cytokine PC rose signiﬁ-
cantly with age and were positively correlated
with schistosome infection (Table 4A) and the
Table 3. Principal components extracted for schistosome-speciﬁc
responses
S. haematobium component
PC1- Schistosome
exposure (Sh-PC1)
PC2-Anti-
schistosome
egg and cercariae
responses (Sh-PC2)
PC3-Adult-worm-
speciﬁc immunity
(Sh-PC3)
Accounts for 36% of
total variation
Accounts for 16% of
total variation
Accounts for 12% of
total variation
CAP IgM 0·879 −0·128 0·173
SEA IgM 0·785 −0·222 0·071
WWH IgM 0·833 −0·235 0·023
CAP IgE 0·355 0·779 0·008
SEA IgE 0·646 0·564 0·036
WWH IgE 0·101 0·409 −0·728
CAP IgG4 0·469 −0·328 −0·141
SEA IgG4 0·637 0·008 −0·019
WWH
IgG4
0−0·138 0·367 0·731
Schistosome-speciﬁc antibody levels were measured against cercariae (CAP), adult
worm (WWH) and egg (SEA) antigens. The loading value of each antibody for each
principal component (PC) are given with variables with strong loadings (0·6 or
<−0·6) are indicated in bold.
Table 4A. Analysis of variance F and (P) values of the factors aﬀecting parasite exposure and immune
responses
Age-group Village
Infection
intensity
Village*
age group
Sh-PC1 (exposure to schistosome infection) 0·9(0·41) 1·02(0·37) 3·25(0·08) 10·04(0·002) 0·67(0·52)
Sh-PC2 (cercariae-peciﬁc IgE responses) 1·68(0·20) 1·98(0·15) 13·57(0·001) 0·01(0·922) 2·16(0·13)
Sh-PC3 (adult worm-speciﬁc IgE) 0·12(0·89) 0·30(0·74) 0·02(0·88) 0·31(0·58) 0·70(0·50)
Pf-PC1 (exposure to Plasmodium infection) 0·85(0·43) 4·07(0·02) 56·0(P<0·001) 1·05(0·31) 0·16(0·84)
Pf-PC2 (Immunity against Plasmodium) 0·85(0·43) 0·27(0·76) 0·53(0·47) 0·13(0·72) 1·02(0·37)
Cytokine –PC (systemic cytokines) 1·85(0·18) 1·13(0·33) 2·76(0·10) 3·97(0·05) 0·60(0·55)
Factors signiﬁcant at P<0·05 are highlighted in bold.
Table 4B. Relationship between parasite-speciﬁc antibody levels and systemic cytokines
Sh-PC1 Sh-PC2 Sh-PC3 Pf-PC1 Pf-PC2
Sh-PC1 (exposure to schistosome infection) —
Sh-PC2 (cercariae-speciﬁc IgE responses) 0·33 (0·02) —
Sh-PC3 (adult worm-speciﬁc IgE) 0·01(0·315) −0·22(0·08) —
Pf-PC1 (exposure to Plasmodium infection) 0·20(0·09) −0·96(0·27) −0·17(0·14) —
Pf-PC2 (Immunity against Plasmodium) −0·191(0·11) 0·03(0·42) 0·19(0·11) −0·34(0·01) —
Cytokine –PC (systemic cytokines) 0·21(0·08) 0·28(0·04) −0·17(0·13) −0·03(0·42) −0·04 (0·39)
Partial correlation (controlling for host sex, age, village and schistosome infection intensity) r-values and (P) values.
Correlations signiﬁcant at P<0·05 are highlighted in bold.
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schistosome-speciﬁc hypersensitivity responses in
Sh-PC2 (Table 4B) after controlling for host age,
sex, village or schistosome infection.
DISCUSSION
The geographical and demographical co-distribution
of Schistosoma haematobium and Plasmodium falci-
parum in Africa means that young children can be co-
infected with both parasites. Despite this overlap, the
burden of these co-infections in children aged 5 years
and under is relatively less studied than in children
aged 6 years and above. Furthermore, there is a
paucity of studies characterizing the nature and de-
velopment of parasite-speciﬁc immune responses to
these parasites in children aged 5 years and below.
Therefore we set out to (1) determine the prevalence
and intensity of infection and co-infection with these
parasites in children aged 1–5 years resident in a
schistosome and Plasmodium endemic area; (2) deter-
mine levels of exposure detected as the presence of
serum antibodies speciﬁc for one or both parasites
and, (3) characterize systemic immune responses
(cytokine and parasite-speciﬁc antibody) in these
young children. By conducting the study in two
villages of diﬀerent schistosome infection levels, the
eﬀect of diﬀerent schistosome transmission dynamics
on immune responses could be compared.
In this study, the overall schistosome infection
prevalence was 14·7% by egg count, with a signiﬁcant
diﬀerence between the two areas. Prevalence in the
high infection area was 23% and 3% in low infection
area. These levels were slightly lower than those diag-
nosed by the presence of anti-egg antibodies (16·7%
overall and 24·4% in Magaya and 7·7% in Chitate),
consistent with a recent report from a study in
Table 5. Principal components extracted for Plasmodium-speciﬁc
responses
P. falciparum component
PC1-Exposure to
Plasmodium falciparum
(Pf-PC1)
PC2-Immunity against
Plasmodium falciparum
(Pf-PC2)
Accounts for 42%
of total variation
Accounts for 24%
of total variation
MSP-119 IgG 0·263 −0·667
MSP-2(Dd2) IgG 0·049 0·735
MSP-2(CH150) IgG 0·627 0·445
Tsz IgM 0·903 −0·110
Tsz IgG 0·900 −0·045
Plasmodium antigens were measured against total schizont (Tsz) and the
recombinant proteins Merozoite Surface protein (MSP)-119, MSP-2(CH150)
and MSP-2(dD2). The loading value of each antibody for each principal
component (PC) are given with variables with strong loadings (0·6 or −0·6) are
indicated in bold.
Fig. 3. Systemic levels of the cytokines. (A) Percentage of people with detectable cytokine levels in their plasma with
95% conﬁdence interval shown. (B) Age-proﬁle for each cytokine. Open bars=1–3 years old, grey bars=3 > to 4 years,
black bars=4 > to 5 years. Standard error of the mean is shown for each bar.
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pre-school Ugandan children exposed to S. mansoni
(Stothard et al. 2011) which showed that serological
diagnosis gave slightly higher but not signiﬁcantly
diﬀerent infection levels . In our study all egg-positive
children were also serologically positive for schisto-
some infection although therewere some egg-negative
children who were positive for anti-egg antibodies.
Not surprisingly, more children showed evidence of
exposure to the infective stage of schistosomes,
cercariae, with 43·4% of the children producing anti-
cercariae IgM (60% in the high infection area and
23·7% in the low infection area) than those that were
positive for infection. The anti-cercariae responses
indicated in part, pre-patent, single sex or low
intensity infections which are not easily diagnosed
by egg count methods (Stothard et al. 2011).
The youngest children showing evidence of
exposure to cercariae antibodies were 3 years and
4 years in the high schistosome infection and low
schistosome infection areas, respectively. This diﬀer-
ence was consistent with the diagnosis of schistosome
infection via microscopic egg counts with the young-
est age at which children started excreting schisto-
some eggs in the urine, 3 years and 4 years and
6 months in the two areas, respectively. We have pre-
viously reported that, in areas of highS. haematobium
infection, children as young as 4 months showed
immunological evidence of exposure to schistosome
cercariae (Woolhouse et al. 2000). Our current study
indicates that, in areas of high schistosome infection,
a large proportion of these young children are
exposed to schistosome cercariae and that this
exposure translates to patent infections in some cases.
The importance of these childhood schistosome
infections is augmented by their potential interaction
with other co-infections such as Plasmodium. Several
studies have reported that co-infected children suﬀer
parasite-related morbidity exacerbated by the pres-
ence of the other parasite (Remoue et al. 2003;
Arinola, 2005; Wilson et al. 2008; Diallo et al. 2010).
Conversely, there have been reports of a negative
association between helminth infections and the
severity of morbidity arising from Plasmodium
infections (Nacher et al. 2000; Lyke et al. 2005).
Experimental and human observational studies
have indicated that the exacerbation of morbidity as
well as negative association between helminth and
Plasmodium infections has an immunological basis
(Remoue et al. 2003; Arinola, 2005; Wilson et al.
2008; Diallo et al. 2010). In this current study, none
of the childrenwere positive forPlasmodium infection
but 13·4% of the children showed evidence of recent
exposure to Plasmodium schizonts. It is unlikely that
this IgM responsewas related tomaternal exposure to
Plasmodium parasites since the youngest child with
anti-schizont levels above those of the controls was
4 years old. All children showing immunological
evidence of exposure to the schizonts were resident in
the low schistosome infection area; the reasons for
this are unclear. Both study areas are mesoendemic
for Plasmodium infection but the diﬀerences in
temporal patterns of the rivers in the two areas that
aﬀect the schistosome transmission dynamics may
aﬀect the breeding sites for the Plasmodiummosquito
vector. There was no association between schisto-
some-speciﬁc and Plasmodium-speciﬁc immune re-
sponses in either village. This is possibly due to the
low level ofPlasmodium endemicity in the area. Thus,
the interactions reported from the other studies
where both the Plasmodium transmission and the
incidence of clinical malaria is higher may be inﬂu-
enced by current levels of parasitaemia experienced
by the children as well as their history of infection
with both parasites. We have previously reported an
interaction between schistosome-speciﬁc antibodies
and P. falciparum from older Zimbabwean children
resident in higher transmission areas for both
parasites (Mutapi et al. 2000, 2007a).
Immune responses against schistosomes and those
against Plasmodium parasites show distinct age
proﬁles (Mutapi et al. 1997; Mutapi et al. 2007b;
Iriemenam et al. 2009). In population studies in-
cluding children aged 6 years and above, schistosome
infection intensity, IgM and total IgG antibodies
follow the typical convex age-infection curve orig-
inally described for schistosome infections by Fisher
in 1934 (Fisher, 1934), i.e. they rise with age peaking
in older children and then decline in adulthood. This
age-proﬁle for IgM and total IgG is largely a result of
age-related exposure patterns to infective water as
well as egg and adult worm antigens (Ndhlovu et al.
1996;Mutapi et al. 1997). Unlike IgM and total IgG,
levels of IgE levels with age (Dunne et al. 1992;
Mutapi et al. 1997) and the ratio of IgE:IgG4, which
has been associated with the development of resist-
ance to infection/re-infection in S. haematobium
infections, also increases with age. This study showed
that these age-related patterns can already be detected
in children under 6 years of age. IgM levels directed
against all parasite stages rose with age consistent
with age-related increases in exposure to infective
Table 6. Principal components extracted for
systemic cytokine levels
Cytokine PC
Accounts for 40%
of total variation
IL-4 −0·377
IL-5 0·780
IL-10 0·674
IFN-γ 0·652
TNF-α 0·587
The loading value of each antibody for each principal
component (PC) are given with variables with strong
loadings (0·6 or −0·6) are indicated in bold.
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water (Woolhouse et al. 2000). Furthermore, IgM
levels rosemore quickly with age in the high infection
area consistent with the existence of peak shifts in
antibody levels in areas of diﬀerent schistosome
infections (Mutapi et al. 1997). Schistosome-speciﬁc
antibody responses were higher in Magaya, the high
schistosome infection area compared to Chitate the
low infection area. This is not surprising as pre-
viously studies have indicated that in the early age
groups schistosome speciﬁc responses are correlated
to the levels of the infections that are stimulating
them (Ndhlovu and Woolhouse, 1996; Mutapi et al.
1997). IgE responses directed against cercariae were
signiﬁcantly higher in the low infection area com-
pared to the high infection area and they declined
with age (although this was not signiﬁcant) which
would be consistent with a reduction in acute
immune hyperactivity to cercarial exposure (swim-
mers’ itch) (Cort, 1928; Kourilova et al. 2004) medi-
ated by IgE antibodies which is observed in residents
of schistosome-endemic areas. This suggests that
by the time these children start school (the young-
est age-group normally enrolled in schisto-
some immuno-epidemiology studies) the early anti-
cercariae responses are already diﬀerent from those
observed at ﬁrst exposure. Thus in this study the
immune responses which are associated with expo-
sure to the parasite antigens are signiﬁcantly related
to schistosome infection. However, immune res-
ponses associated with protection to adult schisto-
somes did not follow distinct patterns with infection.
Similar toPlasmodium infections, acquired immunity
to schistosomes takes several years to develop to
levels suﬃcient to have observed eﬀects on levels
of infection/re-infection (Langhorne et al. 2008;
Woolhouse et al. 1991).
The Plasmodium antibody responses in these
children were reduced into two variables composed
of responses directed against the crude antigens and
MSP-2(CH150) and those directed against MSP-119
and MSP-2(Dd2) suggesting that these variables
were representative of distinct biological processes
associated with putative exposure to parasites
(Naus et al. 2003b) and the development of protective
acquired immunity respectively (Conway et al.
2000; Mawili-Mboumba et al. 2003; Metzger et al.
2003; Polley et al. 2003, 2006; Cavanagh et al. 2004).
These responses were negatively correlated and
Plasmodium-speciﬁc responses indicative of exposure
to parasite antigens declining signiﬁcantly with age
(after controlling for variation to host sex, village,
and schistosome infection). Unlike anti-schistosome
antibody responses, levels of antibodies to several
Plasmodium antigens may vary with the seasonality of
parasite transmission, often being higher during
periods of high transmission than at the end of a
low transmission season (Cavanagh et al. 1998). Fur-
thermore, levels of anti-Plasmodium antibodies tend
to be higher in individuals carrying patent parasite
infections than in those without parasites at the time
of the survey for both crude antigens and recom-
binant antigens such as the vaccine candidates we
studied here (Polley et al. 2006; Osier et al. 2008).
Isotype switching after B cell activation and the
absence of IgM memory responses also means that
levels of circulating anti-Plasmodium IgM responses
decline in favour of a switch to IgG3 responses
typically observed in children (Taylor et al. 1998).
Therefore it is not surprising that immune responses
indicative of recent exposure decline with age and
responses associated with resistance to Plasmodium
did not show distinct patterns with age as these are
still developing.
Systemic cytokines were detected in most children,
with IL-10 being the most prevalent within the
cohort, despite being present at low concentrations
compared to the other cytokines. This is consistent
with results we have previously reported from
Zimbabwean populations showing that levels of
both schistosome-speciﬁc and systemic IL-10 were
low compared to the other cytokines (Mutapi et al.
2007b; Milner et al. 2010). The high prevalence of
IL-10 may be related to its role in isotype switching
to IgG subclasses (Garraud et al. 2003) and its
regulatory function modulating both Th1 and Th2
responses (Hunt and Grau, 2003). The least detected
cytokines were TNF-α and IFN-γ, which are associ-
ated with inﬂammatory Th1-type responses. The
cytokine responses rose with schistosome speciﬁc
anti-egg responses and schistosome infection. We
have previously demonstrated that systemic IL-5 and
IL-4 were correlated with low S. haematobium infec-
tion in putatively resistant individuals (i.e. lifelong
residents of schistosome-endemic areas who, despite
continued exposure to infective water, harbour little
or no schistosome infection) (Milner et al. 2010).
In human Plasmodium infections elevated levels of
both IFN-γ and TNF-α are associated with severe
malaria (Awandare et al. 2006) so that their presence
in children concurrently exposed to helminth and
Plasmodium infections might be expected to exacer-
bate Plasmodium-related pathology. Conversely, low
IL-10plasma levels are associatedwith severemalarial
anemia (Kurtzhals et al. 1998). IL-5 and IL-10 are
associated with protection against re-infection with
schistosomes (Medhat et al. 1998; Abath et al. 2006).
However, there were no signiﬁcant associations be-
tween plasma cytokines and Plasmodium-speciﬁc
antibody levels. This suggests that either the plasma
cytokines reﬂect current parasitic infections which is
consistentwith the signiﬁcant association between the
systemic cytokine levels and schistosome infection, or,
that the dynamics of parasite-speciﬁc and systemic
cytokine diﬀer in this context.
Overall this study has shown that, in both areas
of high and low schistosome infection, children aged
5 years and below show immunological evidence of
exposure to schistosome infection. In areas of high
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schistosome infection, a large proportion of children
aged 5 years and below was excreting schistosome
eggs. Furthermore, the children also show immuno-
logical evidence of exposure to Plasmodium although
none of them were positive for Plasmodium infection.
Both schistosome-speciﬁc and Plasmodium-speciﬁc
responses associated with protection to infection/re-
infection were detected in the children together with
a mixed systemic cytokine phenotype consisting of
both Th1 andTh2 cytokines. The immune responses
measured showed age-related patterns consistent
with those reported in older children, suggesting
that the development of protective acquired immu-
nity starts in early childhood, although the eﬀects
of this immunity on infection levels and pathology
may take time to become apparent.
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